The COW Board is a select group of experts in the management of HIV and other viral infections. Dedicated to teaching practitioners who are actively involved in medical care for people with HIV or other viral infections, the COW Board ensures that the program remains a relevant and useful educational tool for the IAS–USA audience.

Members of the COW Board participate in a volunteer capacity. They are not compensated for their role in overseeing the program. Listed below are the COW Board members.


Board Co-Chair

Michael S. Saag, MD
Professor of Medicine
University of Alabama at Birmingham
Birmingham, Alabama

Dr Saag has received research grants awarded to his institution from Gilead Sciences, Inc, and ViiV Healthcare. (Updated 7/6/22)

Marshall J. Glesby, MD, PhD
Professor of Medicine and Healthcare Policy and Research
Weill Cornell Medicine
New York, New York

Dr Glesby has received research grants awarded to his institution from Gilead Sciences, Inc., and Regeneron Pharmaceuticals; and has served as a consultant to ReAlta Life Sciences, Inc., and Swedish Orphan Biovitrum AB. (Updated 05/31/22)


Board Members

Roger J. Bedimo, MD, MS
Professor of Internal Medicine
University of Texas Southwestern Medical Center
Dallas, Texas

Dr Bedimo has received research grants awarded to his institution from Merck & Co, Inc, and has served on the scientific advisory board for Merck & Co, Inc, ViiV Healthcare, Gilead Sciences, Inc., and Janssen Pharmaceuticals. (Updated 06/28/22)

Kara W. Chew, MD, MS
Assistant Clinical Professor of Medicine
University of California Los Angeles David Geffen School of Medicine
Los Angeles, California

Dr Chew has served as a consulting to Pardes Biosciences and has received research grants awarded to her institution from Merck Sharp & Dohm. (Updated 6/26/22)

Betty J. Dong, PharmD
Professor of Clinical Pharmacy
University of California San Francisco
San Francisco, California

Dr Dong has no relevant financial relationships with ineligible companies to disclose. (Updated 6/21/22)

Steven C. Johnson, MD
Professor of Medicine
University of Colorado School of Medicine
Aurora, Colorado

Dr Johnson has served on an advisory​ board for and received consultation​ fees to his institution from ViiV​ Healthcare. (Updated 6/21/21)

Carrie Down Johnston, MD
Instructor in Medicine
Weill Cornell Medicine
New York, New York

Dr Johnston has served as a consultant to Theratechnologies Inc. (Updated 6/22/21)

Harry W. Lampiris, MD
Professor of Clinical Medicine
University of California San Francisco
San Francisco, California

Dr Lampiris has no relevant financial relationships with ineligible companies to disclose. (Updated 06/10/22)

David L. Wyles, MD
Chief of the Division of Infectious Diseases
Denver Health Medical Center
Denver, Colorado

Dr Wyles has received grant support awarded to his institution from Gilead Sciences, Inc. (Updated 07/19/22)


Planner

Donna M. Jacobsen
Executive Director/President
International Antiviral Society–USA
San Francisco, California

Ms Jacobsen has no relevant financial relationships with ineligible companies to disclose. (Updated 7/18/22)